Phase II study of aclarubicin in non-small cell lung cancer

Cancer Treat Rep. 1987 Mar;71(3):323-4.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aclarubicin
  • Aged
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Drug Evaluation
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Middle Aged
  • Naphthacenes / adverse effects
  • Naphthacenes / therapeutic use

Substances

  • Naphthacenes
  • Aclarubicin